The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. The metric has seen a significant loss of -32.08% since the start of this calendar year. Looking back over the last six months, we
ProQR Therapeutics N.V experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $4.62 on 10/17/24, while the lowest price for the same period was registered at $1.07 on 04/09/25. 52-week price history of PRQR Stock Studying a
The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. ProQR Therapeutics N.V’s current trading price is -71.43% away from its 52-week high, while its distance from the 52-week low is 23.36%. The stock’s price
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. Until today this year the stock’s price performance recorded a decrease of -56.98%. However, over the last six months,
A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. ProQR Therapeutics N.V’s current trading price is -68.40% away from its 52-week high, while its distance from the 52-week low is -2.67%. The stock’s
Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. ProQR Therapeutics N.V’s current trading price is -64.72% away from its 52-week high, while its distance from the 52-week low is 2.52%.
After the company announced an expansion of cooperation, shares of ProQR Therapeutics N.V. (Nasdaq: PRQR) were up 35.15% at $2.23 at the time of our last check in pre-market trading. What partnership will PRQR be extending? Eli Lilly and Company (NYSE: LLY) and ProQR Therapeutics
All rights reserved © 2024, Powered By Smart TechOne
